GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (FRA:49Z) » Definitions » Research & Development

BICO Group AB (FRA:49Z) Research & Development : €28.9 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BICO Group AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BICO Group AB's Research & Development for the three months ended in Sep. 2024 was €6.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was €28.9 Mil.

BICO Group AB Research & Development Historical Data

The historical data trend for BICO Group AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB Research & Development Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

BICO Group AB Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.29 - 14.80 8.07 6.03

BICO Group AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €28.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BICO Group AB  (FRA:49Z) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BICO Group AB Research & Development Related Terms

Thank you for viewing the detailed overview of BICO Group AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BICO Group AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (FRA:49Z) » Definitions » Research & Development
Comparable Companies
OSTO:SEDANA OSTO:BACTI B OSTO:CRAD B OSTO:CEVI OSTO:BRAIN OSTO:MNTC OSTO:SEZI OSTO:INTEG B OSTO:PRO OSTO:STIL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
BCCOY:USA CLLKF:USA BICO:Sweden
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
Website
https://www.bico.com
BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB Headlines

No Headlines